EQT And Mubadala All Set To Acquire Global Biopharma Transport Giant Envirotainer

EQT Private Equity and Mubadala Investment Company will make a majority investment in Envirotainer. It is a global provider of mission-critical cold chain transportation solutions for pharmaceuticals. Moreover, EQT and Mubadala will pay $3 billion for the company. At present, Cinven and Novo Holdings control Envirotainer.

Envirotainer aims to expand access to vital pharmaceuticals and vaccines through its patient-safe and efficient cold chain solutions. These solutions also have the lowest carbon footprint in the industry.

EQT Private Equity and Mubadala plan to support Envirotainer in its next phase of growth. They aim to do this by accelerating expansion in core markets and APAC in particular.

EQT plans to purchase the company from its EQT X fund. The fund will also start char...

Login In


Register now for free access

Notify of
Inline Feedbacks
View all comments